| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.32B | 21.13B | 20.49B | 32.79B | 28.75B | 13.22B |
| Gross Profit | 3.90B | 1.94B | 3.22B | 1.62B | 13.73B | 191.00M |
| EBITDA | 558.00M | -1.14B | 1.80B | -1.59B | 8.41B | -2.68B |
| Net Income | 1.67B | -593.00M | 1.07B | 3.27B | 6.91B | -2.97B |
Balance Sheet | ||||||
| Total Assets | 28.48B | 20.54B | 19.71B | 19.27B | 72.97B | 47.56B |
| Cash, Cash Equivalents and Short-Term Investments | 22.78B | 14.19B | 13.64B | 11.65B | 57.50B | 39.11B |
| Total Debt | 200.00M | 319.00M | 615.00M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.29B | 2.63B | 1.74B | 2.44B | 58.85B | 43.23B |
| Stockholders Equity | 26.19B | 17.91B | 17.97B | 16.83B | 14.11B | 4.32B |
Cash Flow | ||||||
| Free Cash Flow | -157.00M | -8.27B | 2.41B | -9.07B | 2.13B | -470.00M |
| Operating Cash Flow | -124.50M | -7.97B | 2.42B | -9.03B | 2.21B | -459.00M |
| Investing Cash Flow | -115.50M | -742.00M | 120.00M | 13.69B | -259.00M | -203.00M |
| Financing Cash Flow | -78.50M | 236.00M | -164.00M | -564.00M | 2.71B | 3.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥130.19B | 12.17 | ― | 1.22% | -3.37% | 19.40% | |
74 Outperform | ¥83.48B | 5.57 | ― | 1.79% | -15.80% | ― | |
66 Neutral | ¥19.61B | 7.37 | ― | 2.75% | -1.42% | 6.10% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
57 Neutral | ¥84.02B | 48.38 | 7.71% | ― | 28.85% | -9.70% | |
53 Neutral | ¥32.55B | -2.25 | ― | ― | 15.15% | 348.44% |